CCME Global Ltd (CCME) · mywealthgrid

About

CCME Global Ltd operates in Biotechnology within the Healthcare sector.

Face value: ₹10

Market cap

₹54 Cr

P/E

15.4×

P/B

1.3×

Dividend yield

0%

ROE

-2.9%

ROCE

-2.9%

Debt / equity

0

OPM

—

EPS (TTM)

₹2.7

Book value

₹30.8

52-week high

—

52-week low

—

385 historical price candles were omitted because the exchange source has not been verified.

₹41.5-9.7%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0)
+High promoter holding of 74.4% with no pledge

Cons

−Low return on equity of -2% (3-yr avg)

Research score

Structured signal from quality, growth, valuation and momentum.

57/100

Business quality: 33
Valuation: 81

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Anthem Biosciences LimitedANTHEMANTHEM	₹48,213 Cr	₹48,264 Cr	₹2,002 Cr	₹793 Cr	39.3%	₹576 Cr	27.9%	27.6%	19.5%	124
Advanced Enzyme Technologies LimitedADVENZYMESADVENZYMES	₹3,072 Cr	₹3,092 Cr	₹750 Cr	₹224 Cr	30.7%	₹166 Cr	23.3%	13.7%	11.1%	331
CCME Global LtdCCMECCME	₹54 Cr	₹54 Cr	₹0 Cr	₹0 Cr	—	₹4 Cr	—	-2.9%	-2.9%	—
Vivo Bio Tech LtdVIVOBIOTVIVOBIOT	₹38 Cr	₹92 Cr	₹47 Cr	₹21 Cr	44%	₹7 Cr	15.6%	15.2%	11%	517
Shree Ganesh Biotech (India) LtdSHREEGANESSHREEGANES	₹19 Cr	₹19 Cr	₹23 Cr	₹-1 Cr	-19.3%	₹0 Cr	7.7%	0.8%	0.6%	846
Genomic Valley Biotech LtdGVBLGVBL	₹9 Cr	₹9 Cr	₹0 Cr	₹-0 Cr	14.8%	₹-1 Cr	11.1%	1%	0.8%	3,565

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue	—	—	—	—	—	0	0	0	0	0	0
	—	—	—	—	—	0	0	0	4	0	1
	—	—	—	—	—	-0	-0	-0	-4	-0	-1
OPM %	—	—	—	—	—	—	—	—	—	—	—
Depreciation	—	—	—	—	—	0	0	0	0	0	0
Interest	—	—	—	—	—	0	0	0	0	0	0
	—	—	—	—	—	0	0	0	0	4	0
Profit before tax	0	0	-0	-0	-0	-0	-0	-0	-4	4	-1
Tax	—	—	—	—	—	0	0	0	0	0	0
	0	0	-0	-0	-0	-0	-0	-0	-4	4	-1
PAT margin %	—	—	—	—	—	—	—	—	—	—	—
EPS (₹)	0.4	-0	-0.2	—	-0.1	-0.1	—	—	-2.9	2.7	-0.5
EPS adjusted (₹)	—	—	—	—	—	-0.1	-0.1	-0.1	-2.9	2.7	-0.2
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	13	13	13	13	13	45
Reserves	-4	-4	-4	-8	-4	-5
	0	0	0	0	0	0
	0	0	0	0	0	5
Total equity & liabilities	9	9	9	5	9	45
	0	0	0	0	0	0
CWIP	—	0	0	0	0	0
Investments	0	0	0	0	0	0
	9	9	9	5	9	45
Total assets	9	9	9	5	9	45

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0	-0	-0	0	0	5
	—	0	0	0	0	0
	0	0	0	0	0	32
Net cash flow	—	0	0	0	0	37
Free cash flow	—	—	—	0	0	5
CFO / Operating profit %	—	—	—	—	—	—

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	—	—	—	—	—	—
EBITDA margin %	—	—	—	—	—	—	—	—
EBIT margin %	—	—	—	—	—	—	—	—
PAT margin %	—	—	—	—	—	—	—	—
Working capital
Receivable days	—	—	—	—	—	—	—	—
Inventory days	—	—	—	—	—	—	—	—
Payable days	—	—	—	—	—	—	—	—
NWC days	—	—	—	—	—	—	—	—
Leverage
Current ratio	—	—	76.67	69.92	64.07	28.94	—	8.65
Debt to EBITDA	—	—	—	—	—	—	—	—
Debt to equity	—	—	0	0	0	0	0	0
Interest coverage	—	—	—	—	—	—	—	—
Asset turnover	—	—	0	0	0	0	0	0
Return ratios
Return on assets %	—	—	-1.3%	-1.3%	-1.6%	-72.9%	39.6%	-1.6%
Return on capital employed %	—	—	-1.3%	-1.3%	-1.6%	-54.8%	50.6%	-2.9%
Return on equity %	—	—	-1.3%	-1.3%	-1.6%	-75.5%	41%	-1.8%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	74.17%	74.35%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	88.67%	88.67%	88.67%	88.67%	88.67%	88.67%	88.67%	88.67%	88.67%	88.67%	25.83%	25.65%
No. of shareholders	—	—	—	—	—	—	—	—	1,736	1,855	1,938	1,937

Promoter holding up 63.02 percentage points since Sep 2023.

Mr. Padmanaban KrishnamoorthyNon-Executive - Non Independent Director-Chairperson related to Promoter
Mrs. Venkatraman VaralakshmiNon-Executive - Non Independent Director
Mrs. Poonam ChaturvediExecutive Director-MD
Mr. Ashok Chhaganbhai PatelNon-Executive - Independent Director
Ms. Ritika AgrawalNon-Executive - Independent Director
Mr. Ravindranath RajaramChief Financial Officer
Ms. Garima GargCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in CCME Global Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

30

Annual reports

19

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results14 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

35 announcementsExport CSV

21 Aug 2026, 6:19 pmOthers

Board Meeting Outcome for Outcome Of Board Meeting Held On August 21, 2026.

Outcome without intimation PDF

18 Aug 2026, 4:31 pmCompany Update

Announcement under Regulation 30 (LODR)-Demise

Demise PDF

14 Aug 2026, 6:07 pmCompany Update

Statement Of Deviation Of Funds For The Quarter Ended 30Th June 2026

Reg. 32 (1), (3) - Statement of Deviation & Variation PDF

14 Aug 2026, 5:58 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

14 Aug 2026, 5:39 pmResult

Results For The Quarter Ended 30Th June 2026

Financial Results PDF

14 Aug 2026, 5:31 pmBoard Meeting

Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August 2026

Outcome of Board Meeting PDF

10 Aug 2026, 2:59 pmBoard Meeting

Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On 14Th August 2026

Exchange filing PDF

15 Jul 2026, 5:22 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

Date	Category	Subject	Filing
21 Aug 2026, 6:19 pm	Others Outcome without intimation	Board Meeting Outcome for Outcome Of Board Meeting Held On August 21, 2026.	PDF
18 Aug 2026, 4:31 pm	Company Update Demise	Announcement under Regulation 30 (LODR)-Demise

Loading announcements…

CCME Global Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Board meetings1

Announcements

Ratio timeline

Board meetings1

Quarterly record

Board and management

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Return on equity

1

1